Zevalin and mucosal inflammation Patient Reports February 12, 2012



Zevalin Side Effects Report #5824161-2
Zevalin side effect was reported by a Health Professional from FRANCE on July 07, 2008. Female patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: diarrhoea, enterococcal infection, fatigue, hypotension, mucosal inflammation, pathogen resistance, weight decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MEPHALAN, FLUDARA, ENDOXAN. Patient recovered.

Zevalin Side Effects Report #5844597-3
Zevalin side effect was reported by a Health Professional from FRANCE on July 25, 2008. Female patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: basophil count decreased, diarrhoea, enterococcal infection, hypotension, mucosal inflammation, pyrexia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MEPHALAN. Patient recovered.

Zevalin Side Effects Report #5517913-X
Zevalin side effect was reported by a Physician from UNITED STATES on Nov 01, 2007. Male patient, 50 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: intervertebral disc disorder, lymphoma What is  lymphoma, mucosal inflammation, oral mucosal blistering. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #4999809-5
Zevalin side effect was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2006. Male patient, weighting 198.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, febrile neutropenia, fluid overload, hypotension, hypoxia, mucosal inflammation, pancytopenia, pneumonia What is  pneumonia. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN. Patient was hospitalized. Patient died on 05/05/2006.


Zevalin Side Effects Report #6106637-6
Zevalin side effect was reported by a Health Professional from SPAIN on Feb 18, 2009. Male patient, 59 years of age, was diagnosed with mantle cell lymphoma, stem cell transplant and was treated with Zevalin. After drug was administered, patient experienced the following side effects: blood blister, mucosal inflammation, oropharyngeal blistering. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARABINE PHOSPHATE, MELPHALAN, ENALAPRIL, AMCHAFIBRIN. Patient recovered.

Zevalin Side Effects Report #4877479-4
Zevalin side effect was reported by a Consumer or non-health professional from GERMANY on Dec 22, 2005. Female patient, 63 years of age, weighting 163.1 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: depressed level of consciousness, hyporeflexia, mucosal inflammation, obstructive airways disorder. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE AGENTS, ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE AGENTS. Patient recovered.

Zevalin Side Effects Report #4952853-6
Zevalin side effect was reported by a Consumer or non-health professional from GERMANY on Mar 09, 2006. Female patient, 63 years of age, weighting 163.1 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: depressed level of consciousness, dermatitis, hyporeflexia, lung infiltration, mucosal inflammation, obstructive airways disorder, pulmonary toxicity, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient recovered.

Zevalin Side Effects Report #5424463-8
Zevalin side effect was reported by a Health Professional from BELGIUM on Aug 06, 2007. Female patient, 59 years of age, weighting 180.8 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: dermatitis, haemoglobin decreased, mucosal inflammation, platelet count decreased, respiratory failure, stem cell transplant, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, OMEPRAZOLE. Patient recovered.

Zevalin Side Effects Report #4977446-6
Zevalin side effect was reported by a Health Professional from BELGIUM on Mar 15, 2006. Female patient, 59 years of age, weighting 180.8 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: mucosal inflammation, respiratory failure, skin toxicity, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN, ETOPOSIDE, ARACYTINE, MELPHALAN. Patient recovered.


Zevalin Side Effects Report #5872436-3
Zevalin side effect was reported by a Health Professional from FRANCE on Aug 19, 2008. Male patient, 60 years of age, was diagnosed with b-cell unclassifiable lymphoma high grade and was treated with Zevalin. After drug was administered, patient experienced the following side effects: atrial fibrillation What is  atrial fibrillation, febrile bone marrow aplasia, ischaemia, mucosal inflammation, musculoskeletal pain, myopericarditis, pericardial effusion, stem cell transplant, tachycardia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5857204-0
Zevalin side effect was reported by a Health Professional from FRANCE on Aug 05, 2008. Female patient, 62 years of age, was diagnosed with b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatinine increased, blood urea increased, bone marrow transplant What is  bone marrow transplant, depression What is  depression, diabetes mellitus, diarrhoea, mucosal inflammation, multi-organ failure. Zevalin dosage: unknown. During the same period patient was treated with MABTHERA, CARMUSTINE, ARACYTINE, ETOPOSIDE, ALKERAN. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #6136219-1
Zevalin side effect was reported by a Physician from SPAIN on Mar 25, 2009. Male patient, 52 years of age, weighting 165.3 lb, was diagnosed with b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, diarrhoea, liver injury, mucosal inflammation, multi-organ failure, neutropenia. Zevalin dosage: unknown. During the same period patient was treated with YTRACIS, RITUXIMAB, FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE. Patient died on 03/17/2009.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Zevalin